1. Home
  2. ALVO vs RYN Comparison

ALVO vs RYN Comparison

Compare ALVO & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVO
  • RYN
  • Stock Information
  • Founded
  • ALVO 2013
  • RYN 1926
  • Country
  • ALVO Luxembourg
  • RYN United States
  • Employees
  • ALVO N/A
  • RYN N/A
  • Industry
  • ALVO Biotechnology: Pharmaceutical Preparations
  • RYN Real Estate Investment Trusts
  • Sector
  • ALVO Health Care
  • RYN Real Estate
  • Exchange
  • ALVO Nasdaq
  • RYN Nasdaq
  • Market Cap
  • ALVO 4.0B
  • RYN 4.5B
  • IPO Year
  • ALVO N/A
  • RYN N/A
  • Fundamental
  • Price
  • ALVO $12.44
  • RYN $25.69
  • Analyst Decision
  • ALVO Buy
  • RYN Hold
  • Analyst Count
  • ALVO 1
  • RYN 4
  • Target Price
  • ALVO $18.00
  • RYN $31.00
  • AVG Volume (30 Days)
  • ALVO 193.2K
  • RYN 761.9K
  • Earning Date
  • ALVO 03-19-2025
  • RYN 02-05-2025
  • Dividend Yield
  • ALVO N/A
  • RYN 4.44%
  • EPS Growth
  • ALVO N/A
  • RYN 98.46
  • EPS
  • ALVO N/A
  • RYN 1.07
  • Revenue
  • ALVO $393,919,000.00
  • RYN $1,004,107,000.00
  • Revenue This Year
  • ALVO $398.12
  • RYN N/A
  • Revenue Next Year
  • ALVO $44.73
  • RYN N/A
  • P/E Ratio
  • ALVO N/A
  • RYN $24.10
  • Revenue Growth
  • ALVO 517.92
  • RYN 20.26
  • 52 Week Low
  • ALVO $9.15
  • RYN $24.88
  • 52 Week High
  • ALVO $18.00
  • RYN $35.29
  • Technical
  • Relative Strength Index (RSI)
  • ALVO 42.13
  • RYN 38.96
  • Support Level
  • ALVO $12.36
  • RYN $25.82
  • Resistance Level
  • ALVO $12.96
  • RYN $26.50
  • Average True Range (ATR)
  • ALVO 0.35
  • RYN 0.54
  • MACD
  • ALVO -0.13
  • RYN 0.09
  • Stochastic Oscillator
  • ALVO 27.15
  • RYN 8.56

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

About RYN Rayonier Inc. REIT

Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. The firm also owns timberland in New Zealand. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.

Share on Social Networks: